Sunday, September 27, 2015

Nivolumab drug significantly prolongs survival in advanced kidney cancer patients

Nivolumab drug significantly prolongs survival in advanced kidney cancer patients
Posted by at No comments:

Saturday, September 26, 2015

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)
Posted by at No comments:

Thursday, August 20, 2015

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions
Posted by at No comments:

Sunday, June 21, 2015

Lilly announces positive results from LY2951742 Phase 2b study in patients with episodic migraine

Lilly announces positive results from LY2951742 Phase 2b study in patients with episodic migraine
Posted by at No comments:

Tuesday, June 2, 2015

ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors

ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors
Posted by at No comments:

Monday, June 1, 2015

MEDI4736 and tremelimumab combination shows acceptable safety, potential efficacy in NSCLC patients

Posted by at No comments:

Sunday, May 31, 2015

Immunotherapy combo increases progression-free survival in advanced melanoma patients..........

Immunotherapy combo increases progression-free survival in advanced melanoma patients ..
Posted by at No comments:
Subscribe to: Posts (Atom)